X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JNCI-Journal of the National Cancer Institute

期刊標題檢索 JNCI-J NATL CAN 最新評論: Hello, may I ask what will happen next? (2024-03-03)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JNCI-Journal of the National Cancer Institute]您好,您是該頁面的第 42940 位訪客。

期刊簡介
期刊名稱JNCI-Journal of the National Cancer Institute JNCI-Journal of the National Cancer Institute

According to the latest JCR data, this journal is indexed in the JCR. A previous title of this journal is J NATL CANCER I)
LetPub Score
9.0
50 ratings
Rate

Reputation
10.0

Influence
8.0

Speed
9.7

期刊簡稱JNCI-J NATL CANCER I
ISSN0027-8874
E-ISSN1460-2105
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
17.004.9862.556
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q128 / 404
Category: Medicine
Subcategory: Cancer Research
Q121 / 230

自引率 (2023-2024)3.00%自引率趨勢
掲載範囲
The Journal of the National Cancer Institute publishes peer-reviewed original research from around the world and is internationally acclaimed as the source for the most up-to-date news and information from the rapidly changing fields of cancer research and treatment. For the past several years, the JNCI has been ranked as one of the most-cited original-research cancer journals by the Institute of Scientific Information in its annual Journal Citation Reports.
官方網站http://jnci.oxfordjournals.org/
在線稿件提交
開放訪問No
出版商Oxford University Press
主題領域ONCOLOGY
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數183每年文章數趨勢
黃金OA百分比31.79%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ128/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0027-8874%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據:
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【JNCI-Journal of the National Cancer Institute】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE643796
    BIOMATERIALS595186
    BIOMEDICINE & PHARMACOTHERAPY498533
    Frontiers in Pharmacology498245
    JOURNAL OF ETHNOPHARMACOLOGY488003
    Journal of Materials Chemistry B476123
    Frontiers in Immunology460315
    COLLOIDS AND SURFACES B-BIOINTERFACES419400
    COMPUTERS IN BIOLOGY AND MEDICINE418387
    Frontiers in Oncology415024
  •  

    JNCI-Journal of the National Cancer Institute JNCI-Journal of the National Cancer Institute
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [JNCI-Journal of the National Cancer Institute] 的評論撰寫評論
作者: 神古怡月


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-03 11:54:45 評論於
Hello, may I ask what will happen next?
(0) 讚! | 神古怡月

作者: 重阳悦爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-04 09:17:31 評論於
Review speed: 3.0 | Submission success rate: 25.0
Experience sharing: A very good journal, but it has been a bit lonely in recent years, not easy to get in
(0) 讚! | 重阳悦爱

作者: Colby Richards


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-01 22:17:27 評論於
Under consideration, sent for external review in 5 weeks
(0) 讚! | Colby Richards

作者: 宫古昌茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-30 21:39:44 評論於
It's over. I was rejected directly after being under consideration for a week. Wahhh
(0) 讚! | 宫古昌茂

作者: 宫古昌茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-30 09:43:21 評論於
Submission acceptance rate: 25.0
Emphasis research direction: Thyroid tumors
Experience sharing: 
Submission Technical Check Started: One week
Under consideration: One week
Rejected
(0) 讚! | 宫古昌茂

作者: 宫古昌茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-29 16:02:38 評論於
Oh, this
(0) 讚! | 宫古昌茂

作者: 宫古俊宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-29 09:16:36 評論於
Don't worry, I have been here for 40 days
(0) 讚! | 宫古俊宇

作者: 宫古昌茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-24 23:58:09 評論於
My status just changed to "under consideration," and when I tried to check the forum, I saw your comment... Help!
(0) 讚! | 宫古昌茂

作者: Colby Richards


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-18 08:58:37 評論於
Research Focus: Tumor Experience Sharing: It has been 4 weeks since submission, under consideration
(0) 讚! | Colby Richards

作者: Colby Richards


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-13 20:17:15 評論於
Is it possible that there has been no external review if my submission has been under consideration for 3 weeks after being submitted?
(0) 讚! | Colby Richards

作者: 语梦小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-08 15:09:59 評論於
Excuse me, may I ask what is the reason for this?
(0) 讚! | 语梦小娘子

作者: 辉夜一莹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-05 14:25:56 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Focused research area: Cancer
Experience sharing: The journal mainly accepts clinically relevant articles with innovative perspectives and new cancer treatment proposals, supported by detailed and rigorous clinical data. After 15 years, it receives fewer basic research articles, but is still a very good journal
(0) 讚! | 辉夜一莹

作者: 坠星鸿宝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-18 14:23:01 評論於
It quickly became "review complete," does that mean it's an instant rejection? But the editor hasn't sent a rejection letter yet
(0) 讚! | 坠星鸿宝

作者: 坠星鸿宝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-18 12:53:40 評論於
It quickly became "review complete." Is it a rejection, but the editor still hasn't sent a rejection letter, more than a week has passed
(0) 讚! | 坠星鸿宝

作者: 坠星鸿宝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-11 19:03:16 評論於
How did it go? I encountered the same situation
(0) 讚! | 坠星鸿宝

作者: 坠星鸿宝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-11 17:33:57 評論於
How long does it take for the editor to make a decision letter?
(0) 讚! | 坠星鸿宝

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:01:46 評論於
The common types of SCI articles include Article, Letter, Comments, Review, Protocol, and Review
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 10:30:39 評論於
The common research-oriented types of SCI articles include Article, Letter, Protocol, etc
(0) 讚! | 维尔娜菲茨杰拉德

作者: 魂魄彦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 21:09:47 評論於
What are the common types of SCI articles?
(0) 讚! | 魂魄彦露

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 13:42:56 評論於
What is the most common or frequently written type of SCI articles when we do research?
(0) 讚! | 上清雨真

作者: 一阳梓奥


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-12 18:38:55 評論於
It quickly becomes "review complete," does it mean instant rejection?
(0) 讚! | 一阳梓奥

作者: 宗室访波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-11-12 13:13:09 評論於
It should still be in the hands of the editor
(0) 讚! | 宗室访波

作者: 甲寅mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-07 21:29:01 評論於
What does "under consideration" mean? Is it still in the hands of the editor or undergoing external review?
(0) 讚! | 甲寅mm

作者: 甲寅mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-10-07 17:20:42 評論於
Yes
(0) 讚! | 甲寅mm

作者: 永安小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-15 20:14:38 評論於
Is it necessary to request this step? Thank you
(0) 讚! | 永安小可爱

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [JNCI-Journal of the National Cancer Institute] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*